Catch the cancer; towards a cfDNA-based test for colorectal cancer screening
- Conditions
- colorectal cancercolorectal carcinoma100180181001799010017991
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Individuals participating in the Dutch national colorectal cancer screening program who:
- Have a positive FIT (fecal immunohistochemical test), prior to sequential colonoscopy (performed in the Erasmus MC);
- Grant informed consent to participate in this study;;Lynch Syndrome carriers under surveillance of gastroenterologists in the Erasmus MC, who:
- Have proven Lynch syndrome (DNA mismatch repair mutation);
- Are >=18 years;
- Grant informed consent to participate in this study.
Individuals participating in the Dutch national colorectal cancer screening program who:
- Are known to be carrier of a genetic predisposition for colorectal cancer (for example Familial Adenomatous Polyposis or MUTYH Associated Polyposis);
- Have a negative FIT;
- Have a positive FIT with sequential colonoscopy already performed;
- Are unwilling to undergo colonoscopy or receive unexpected, but relevant and actionable findings;
- Underwent a failed colonoscopy;;Lynch Syndrome carriers who:
- Are unwilling to undergo colonoscopy or receive unexpected, but relevant and actionable findings;
- are <18 years;
- underwent a failed colonoscopy.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The agreement between cfDNA profiles and DNA profiles of corresponding lesions<br /><br>found during regular colonoscopy. </p><br>
- Secondary Outcome Measures
Name Time Method <p> The extent of psychological burden caused by this screening tool.</p><br>